Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced it has commenced an underwritten public offering of $75,000,000 of shares of its ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Equity Offerings

Coherus BioSciences (CHRS) Prices 5.17M Share Common Offering at $14.50/ShMay 23, 2018 5:38 AM Coherus Announces Proposed Public Offering of Common StockMay 21, 2018 4:15 PM